|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
1R21CA217137-01
|
$209,093
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-18
|
$421,563
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
|
5UH2CA202723-02
|
$498,956
|
ERICKSON, DAVID
|
CORNELL UNIVERSITY
|
|
Viral Oncology Training Grant
|
3T32CA009111-38S1
|
$13,628
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-39
|
$387,094
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA015704-42S1
|
$249,999
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S2
|
$125,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S3
|
$58,085
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S4
|
$70,220
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-42
|
$9,559,285
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-04
|
$688,290
|
PHIPPS, WARREN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
|
1R01CA217138-01
|
$644,421
|
WARREN, EDUS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Mechanism and Function of Mitophagy Regulation by HHV-8 Viral Interferon Regulatory Factor-1
|
1R01CA214131-01A1
|
$351,741
|
CHOI, YOUNG BONG
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
2P30CA006973-54
|
$7,060,038
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S1
|
$125,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S2
|
$60,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S3
|
$25,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-16
|
$384,750
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
N/A
|
National Institutes of Health
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
4R44CA206788-02
|
$939,552
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
5R44CA192859-03
|
$866,508
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
Barr, Frederic
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,201,344
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$245,217
|
Burke, Terrence
|
CCR (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$842,389
|
Carrington, Mary
|
CCR (NCI)
|
|
HIV and Cancer
|
ZIA CP010150-10071
|
$90,450
|
Engels, Eric
|
DCEG (NCI)
|
|
Cancer Risk in Solid Organ Transplant Recipients
|
ZIA CP010150-10362
|
$143,962
|
Engels, Eric
|
DCEG (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$587,732
|
Gottesman, Michael
|
CCR (NCI)
|
|
Studies on drug resistance in HIV-related Kaposi's sarcoma
|
ZIA BC 011730
|
$83,962
|
Gottesman, Michael
|
CCR (NCI)
|
|
Medical Oncology HIV-AIDS Clinical Research
|
ZID BC 011683
|
$200,544
|
Gulley, James
|
CCR (NCI)
|
|
KSHV/HHV8 in sickle cell and other Ugandan populations
|
ZIA CP010176-10076
|
$4,601
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
KS gene expression & clonality
|
ZIA CP010176-10082
|
$4,601
|
Mbulaiteye, Sam
|
DCEG (NCI)
|
|
CCR VB FACS CORE
|
ZIC BC 010936
|
$340,513
|
McKinnon, Katherine
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$42,641
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development
|
ZIA BC 010524
|
$193,214
|
Nicklaus, Marc
|
CCR (NCI)
|
|
DNA Vaccines
|
ZIA BC 010749
|
$1,507,952
|
Pavlakis, George
|
CCR (NCI)
|
|
Molecular Diagnostics Core Laboratory
|
ZIC BC 011079
|
$1,554,465
|
Raffeld, Mark
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Humoral Immunity
|
ZIA BC 011058
|
$1,984,075
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Cellular Immunity
|
ZIA BC 011062
|
$566,879
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Translation to the Clinic
|
ZIA BC 011063
|
$283,439
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Biostatistics and Data Management Section
|
ZID SC 007202
|
$578,591
|
Steinberg, Seth
|
CCR (NCI)
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$317,262
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Patient Oriented Research in Viral Malignancies and HIV-associated Cancers
|
ZIA BC 011700
|
$55,714
|
Uldrick, Thomas
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|